Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.
Babaoglu
Melih O
MO
Karadag
Omer
O
Saikawa
Yutaka
Y
Altundag
Kadri
K
Elkiran
Tamer
T
Yasar
Umit
U
Bozkurt
Atila
A
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D001772:Blood Cell Count; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D004176:Dipyridamole / Q000009:adverse effects*; D004347:Drug Interactions; D017809:Fatal Outcome; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D010975:Platelet Aggregation Inhibitors; D003561:Cytarabine; D004176:Dipyridamole